BIOLASE TO PRESENT AT LD MICRO INVITATIONAL INVESTOR CONFERENCE ON JUNE 8, 2022
BIOLASE, a leader in dental lasers, announced its participation in the 2022 LD Micro Invitational investor conference on June 8, 2022, at 3:30 PM PST.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BIOLASE, a leader in dental lasers, announced its participation in the 2022 LD Micro Invitational investor conference on June 8, 2022, at 3:30 PM PST. CEO John Beaver will present to both live and virtual audiences. The conference runs from June 7-9, 2022, and aims to connect investors with innovative companies. BIOLASE develops and sells laser systems for various dental procedures, boasting over 43,300 systems sold globally to date. For more details, register to watch the presentation online.
Details
News Market Reaction – BIOL
The recorded move for BIOL in the trading session of this news was -0.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAKE FOREST, Calif., June 2, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it will be presenting at the 2022 LD Micro Invitational, a prominent three-day investor conference, at the Four Seasons Hotel Westlake Village on Wednesday, June 8, 2022 at 3:30 PM PST / 6:30 PM EST. President and Chief Executive Officer, John Beaver, will be presenting to a live and virtual audience.
Register to watch the event here: https://ldinv12.mysequire.com/
The LD Micro Invitational will take place June 7-9, 2022 and will be available virtually on the Sequire Virtual Events platform.
View BIOLASE's profile here: http://www.ldmicro.com/profile/BIOL
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 301 patented and 32 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
For further information, please contact:
Investors:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-to-present-at-ld-micro-invitational-investor-conference-on-june-8-2022-301559852.html
SOURCE BIOLASE, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.